A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide-containing regimens
- Resource Type
- Source
- British Journal of Haematology. 176:440-447
- Subject
Male Oncology medicine.medical_specialty Population Neutropenia Pharmacology Hydroxamic Acids Dexamethasone Disease-Free Survival 03 medical and health sciences 0302 clinical medicine Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Humans education Lenalidomide Vorinostat Multiple myeloma Aged Aged, 80 and over Salvage Therapy education.field_of_study business.industry Remission Induction Hematology Middle Aged medicine.disease Thalidomide Regimen Treatment Outcome 030220 oncology & carcinogenesis Female Multiple Myeloma business Progressive disease 030215 immunology medicine.drug - Language
- ISSN
- 0007-1048